NASAL METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS CARRIAGE IN PRE AND POST-OPERATIVE PATIENTS IN A TERTIARY HEALTH FACILITY IN UYO, SOUTH-SOUTH, NIGERIA

Journal Title: World Journal of Pharmaceutical Research - Year 2017, Vol 6, Issue 5

Abstract

Methicillin-resistant Staphylococcus aureus is responsible for a greater number of hospital acquired infections which are difficult to treat in humans. Infection increases when unsuspected patients with community-acquired strains are placed in situations that require longterm intensive nursing interventions and cross-infections spreading from patient to patient do occur. This study aimed to determine the nasal Methicillin-resistant Staph. aureus carriage in pre and postsurgical patients and also assess its multi-drug resistant pattern. Nasal swabs were collected from the anterior nares of patients on the same day of admission into the hospital wards, and 48-96 hours after surgery. Samples were analyzed using standard microbiological methods, while antimicrobial susceptibility testing was done using the improved Kirby-Bauer disc diffusion method. Staph. aureus isolates resistant to Cefoxitin and Oxacillin discs, were phenotypically regarded as Methicillin-resistant. Of the 130 samples, 26(40.0%) from pre-operative patients yielded Staph. aureus while additional 15(23.1%) from the erstwhile non-infected patients were detected after surgery. MRSA prevalence were 9.8% and 26.8% from pre-operative and post-operative patients, respectively. Four(15.4%) of the 26 pre-operative Staph. aureus isolates and 11(73.3%) of the 15 post-operative isolates were identified as MRSA. All the MRSA strains exhibited high resistance to Ciprofloxacin (80.0%), Trimethoprim/Sulphamethoxazole (73.3%), Tetracycline(66.7%), Erythromycin(66.7%) and Gentamycin(66.7%). Low resistance was observed with Vancomycin(6.7%) and Clindamycin(26.7%). All the MRSA strains exhibited multi-drug resistance in the combination of 4-8 antibiotics. The high rate of nasal MRSA colonization among pre-operative and post-operative patients signifies serious public health concern and emphasizes the need for a regular surveillance to forestall spread of multidrug resistance and nosocomial infections.

Authors and Affiliations

Moses A. E.

Keywords

Related Articles

EARLY OUTCOME, MORTALITY AND MAJOR MORBIDITY AFTER LUNG CANCER SURGERY FOR PRIMARY CARCINOMA

Background: Radical surgical resection of lung cancer with or without adjuvant treatment is still a prerequisite for cure. Advances in operative and postoperative care led to a decline in complications and mortality rate...

CHANGES IN BLOOD PARAMETERS AND IRON STATUS OF OSTEOPOROSIS WOMEN IN BASRA PROVINCE / IRAQ

Osteoporosis is characterized by low bone mass, deterioration of bone tissue and disruption of bone architecture, compromised bone strength and an increase in the risk of fracture. Blood have different function and play...

IN VITRO DNA DAMAGE INHIBITION ACTIVITY OF AQUEOUS AND ETHYL ACETATE EXTRACT OF VERNONIA AMYGDALINA LEAVES

Vernonia amygdalina (Asteraceae) is a plant widely used both for nutritional and medicinal purposes throughout tropical Africa. Its health-promoting ability might be related to the effect various bioactive components of...

DENGUE FEVER WITH THROMBOCYTOPENIA: PEDIATRIC CASE REPORT

Dengue viral infection is a global health threat and it is the most rapidly spreading mosquito-borne viral disease in the world. A case of 9-year-old boy patient medically free presented to the emergency department with...

EVALUATION OF BIOACTIVE COMPONENTS OF PARINARI EXCELSA SEED OIL

This study investigated the bioactive components of seed oil of Parinari excelsa fruit using GC-MS (HP 6890 and mass spectrometer model 5973 AgilentTech). The result showed that twenty six (26) components were identified...

Download PDF file
  • EP ID EP617615
  • DOI -
  • Views 138
  • Downloads 0

How To Cite

Moses A. E. (2017). NASAL METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS CARRIAGE IN PRE AND POST-OPERATIVE PATIENTS IN A TERTIARY HEALTH FACILITY IN UYO, SOUTH-SOUTH, NIGERIA. World Journal of Pharmaceutical Research, 6(5), 160-171. https://europub.co.uk/articles/-A-617615